4 results
To test the impact of the addition of axitinib to standard chemotherapy treatment on histology samples
To compare the efficiency and safety of Continuous subcutaneous glucose monitoring compared to our standard care (bloodsamples obtained from an arterial or venous bloodsample and measured by the AccuChek.
Sub-study APhase 1b:To assess the DLT rate and estimate the MTD of sasanlimab in combination with encorafenib and binimetinib to determine the RP2D for the combination. Phase 2:To assess the durable ORR of sasanlimab in combination with encorafenib…
Primary ObjectiveTo demonstrate that avelumab in combination with axitinib is superior to sunitinib monotherapy in prolonging PFS or OS in the first-line treatment of PD-L1 positive patients with aRCC.Secondary Objectives* To demonstrate that…